Opening Time:

Monday to Friday
9am-5pm

Spravato (esketamine)
A Prescription Nasal Spray

What is Spravato?

Spravato is a prescription medicine, used along with an antidepressant, taken by mouth to treat: Adults with treatment-resistant depression (TRD) Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions.

Mental health professionals tend to prescribe esketamine nasal spray for its effectiveness. Patients who are on oral antidepressants can benefit for further treatment augmentation.

Depression, antidepressants, and esketamine nasal spray treatments

Nerve endings rely on compounds known as neurotransmitters. Three main neurotransmitters regulate mood and emotional response in the brain:

  • Serotonin, a chemical that regulates emotions like anxiety, happiness, and general mood
  • Dopamine, a feel-good chemical that rewards the brain for actions like running (jogger’s high) or eating
  • A special Neurotransmitter that affects energy and concentration

Antidepressants work to further regulate various neurotransmitters which in turn helps improve mood and function. Unfortunately, antidepressant drugs will not provide optimal relief or be tolerated by everyone.

This is where newer innovative treatments like esketamine come into play. Esketamine works by NMDA receptor antagonism which in turn helps regulate glutamate, a fourth type of neurotransmitter. This mechanism of action helps differentiate Esketamine from most other antidepressants.

Benefits of Spravato nasal spray treatment

Esketamine nasal spray treatments like Spravato are fast-acting and effective. This therapy improves a patient’s mood regulation as the patient pursues long-term treatment for depression. The positive effects of the treatment can include an increase in glutamate levels, which leads to the creation of new neural paths, leading to an increase in brain activity. This, in turn, leads to an uptick in the production and release of beneficial neurotransmitters. This translates to a considerable improvement of brain function and mood regulation.

In other words, the treatment tackles many of the symptoms that come with depression. Esketamine can also decrease the frequency of suicidal thoughts, which helps with severe depression.

Spravato FAQ

You cannot take Spravato on your own. You will administer Spravato nasal spray yourself under the supervision of a healthcare provider, at a certified Spravato treatment center. Because of the risks for sedation, dissociation, and abuse and misuse, Spravato can only be administered at healthcare settings certified in the Spravato Risk Evaluation and Mitigation Strategy (REMS) Program.

While Spravato is often an effective way to treat treatment-resistant depression, not all patients see noticeable improvements to their condition. Anyone who is not getting the desired results with Spravato should talk to their doctor about alternative ways to treat their depression.

Clinical studies found that patients who took Spravato for treatment-resistant depression typically saw improvements to their symptoms about four weeks after starting their treatments, compared to those who took a placebo nasal spray.

Yes, patients should avoid operating machinery and activities that require them to be alert until they have a full night’s rest after taking Spravato. This means patients need to arrange for transportation to and from the clinic on treatment days. They also have to plan their schedule because their ability to concentrate will be limited for the rest of the day. 

At each visit, we will ask about your symptoms of depression, side effects and whether or not you are experiencing noticeable improvement. In the clinical studies of Spravato, a standardized scale called the Montgomery-Åsberg Depression Rating Scale was used to track treatment-resistant depression symptoms and response to treatment.

FDA Approved Esketamine

Welcome to the New Dawn of Depression Treatment

It’s always darkest before dawn. Regardless of how lost you’re feeling and if past therapies failed you, there is always hope. Spravato treatment offered by NeuroMod Health is the first-of-its kind medicine approved by the FDA in the United States to treat adults with treatment-resistant depression (TRD) and to treat Major depressive disorder with suicidal ideation.

The First FDA-Approved Nasal Spray

Here’s what you can expect from Spravato

Icon

Previous treatments failed you

You tried different antidepressants, but still, the symptoms of depression remained. This means you might have treatment-resistant depression (TRD).

For adults with TRD, Spravato targets the N-methyl-D-aspartate (NMDA) receptor and is believed to have a different effect than other oral antidepressants currently available on the market.

Icon

Explore a new promising alternative

You will receive all the information you require within a safe, supportive environment to make an informed decision on how to move forward.

We will do our individual assessment to determine if Spravato is the correct treatment for you and verify your insurance information to confirm eligibility.

Icon

Your journey to a hopeful tomorrow

We have competent, REM certified staff to monitor you throughout treatment.

You will be in a private, serene room for 2 hours following administration of medication, where you may rest comfortably and feel well cared for.

Icon

Previous treatments failed you

You tried different antidepressants, but still, the symptoms of depression remained. This means you might have treatment-resistant depression (TRD). For adults with TRD, Spravato targets the N-methyl-D-aspartate (NMDA) receptor and is believed to have a different effect than other oral antidepressants currently available on the market.

Icon

Explore a new promising alternative

Your first session will be a relaxing, informative consultation. You will receive all the information you require within a safe, supportive environment to make an informed decision on the way forward. We will do our individual assessment to determine if Spravato is the correct treatment for you and verify your insurance information to confirm eligibility.

Treatment Willowbrook, IL | NeuroMod Health

Feel More At Ease By Knowing What to Expect

Please enable JavaScript in your browser to complete this form.

Insurance Coverage

Ensuring a smooth journey ahead

We’ll ensure that your new chapter in life starts without surprises and disappointments.

Although Spravato treatment is covered by the top insurance plans, they still have different requirements due to the specific patient’s treatment history.

We’ll make sure that you are eligible for the medication and the treatment we provided by investigating and gaining confirmation from your insurer.
Logo

Embrace the possibility of new beginnings

Your bold journey toward betterment isn’t always an easy one- we know.

Keep your hope alive, and contact us to learn about treatment solutions for your specific needs.

Ready to renew your life?

Learn more about NeuroMod Health’s strategy for igniting hope in your life once more.

Reach out to us today to learn more about TMS therapy or to schedule an appointment

Location:

NeuroMod Health
555 Plainfield Rd
STE F Unit 1
Willowbrook, IL 60527

Call Us:

630-850-0604

Email:

contact@neuromodhealth.com

Please enable JavaScript in your browser to complete this form.
Preferred Form of Communication
background